350 related articles for article (PubMed ID: 23147197)
1. Drugging the undruggable: transcription therapy for cancer.
Yan C; Higgins PJ
Biochim Biophys Acta; 2013 Jan; 1835(1):76-85. PubMed ID: 23147197
[TBL] [Abstract][Full Text] [Related]
2. Drugging Undruggable Molecular Cancer Targets.
Lazo JS; Sharlow ER
Annu Rev Pharmacol Toxicol; 2016; 56():23-40. PubMed ID: 26527069
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations in cancer and personalized cancer treatment.
Miozzo M; Vaira V; Sirchia SM
Future Oncol; 2015; 11(2):333-48. PubMed ID: 25591842
[TBL] [Abstract][Full Text] [Related]
4. Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective.
Pei H; Guo W; Peng Y; Xiong H; Chen Y
Med Res Rev; 2022 Jul; 42(4):1607-1660. PubMed ID: 35312190
[TBL] [Abstract][Full Text] [Related]
5. Drugging RAS: Know the enemy.
Papke B; Der CJ
Science; 2017 Mar; 355(6330):1158-1163. PubMed ID: 28302824
[TBL] [Abstract][Full Text] [Related]
6. Drugging the 'undruggable'. Therapeutic targeting of protein-DNA interactions with the use of computer-aided drug discovery methods.
Radaeva M; Ton AT; Hsing M; Ban F; Cherkasov A
Drug Discov Today; 2021 Nov; 26(11):2660-2679. PubMed ID: 34332092
[TBL] [Abstract][Full Text] [Related]
7. Drugging "undruggable" genes for cancer treatment: Are we making progress?
Duffy MJ; Crown J
Int J Cancer; 2021 Jan; 148(1):8-17. PubMed ID: 32638380
[TBL] [Abstract][Full Text] [Related]
8. Cell surface GRP78 signaling: An emerging role as a transcriptional modulator in cancer.
Gopal U; Pizzo SV
J Cell Physiol; 2021 Apr; 236(4):2352-2363. PubMed ID: 32864780
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Modulation of Transcriptional Coregulators in Cancer.
Bishop TR; Zhang Y; Erb MA
Trends Pharmacol Sci; 2019 Jun; 40(6):388-402. PubMed ID: 31078321
[TBL] [Abstract][Full Text] [Related]
10. Targeting the GLI family of transcription factors for the development of anti-cancer drugs.
Dusek CO; Hadden MK
Expert Opin Drug Discov; 2021 Mar; 16(3):289-302. PubMed ID: 33006903
[TBL] [Abstract][Full Text] [Related]
11. Targeting FGFR Signaling in Cancer.
Touat M; Ileana E; Postel-Vinay S; André F; Soria JC
Clin Cancer Res; 2015 Jun; 21(12):2684-94. PubMed ID: 26078430
[TBL] [Abstract][Full Text] [Related]
12. Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs.
Klampfer L
Curr Cancer Drug Targets; 2006 Mar; 6(2):107-21. PubMed ID: 16529541
[TBL] [Abstract][Full Text] [Related]
13. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
14. Drugging Chromatin in Cancer: Recent Advances and Novel Approaches.
Cai SF; Chen CW; Armstrong SA
Mol Cell; 2015 Nov; 60(4):561-70. PubMed ID: 26590715
[TBL] [Abstract][Full Text] [Related]
15. An overview of the mTOR pathway as a target in cancer therapy.
Gentzler RD; Altman JK; Platanias LC
Expert Opin Ther Targets; 2012 May; 16(5):481-9. PubMed ID: 22494490
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery.
Martin RD; Hébert TE; Tanny JC
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397434
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
18. STAT proteins as novel targets for cancer drug discovery.
Turkson J
Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
[TBL] [Abstract][Full Text] [Related]
19. Targeting Transcription Factors for Cancer Treatment.
Lambert M; Jambon S; Depauw S; David-Cordonnier MH
Molecules; 2018 Jun; 23(6):. PubMed ID: 29921764
[TBL] [Abstract][Full Text] [Related]
20. Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.
Ray U; Roy SS
FEBS J; 2018 Feb; 285(3):432-443. PubMed ID: 28971574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
